The following is a summary of “Association of Glucagon-like Peptide-1 Receptor Agonists with Optic Nerve and Retinal Adverse ...

A consensus statement from the Society for Perioperative Assessment and Quality Improvement recommends patients should ...

Delhi High Court bars Dr Reddy's and OneSource from selling semaglutide in India, supporting Novo Nordisk's patent rights as ...

The phase 3 trial success over Lilly’s Trulicity (dulaglutide), an already-marketed GLP-1 class rival, further bolsters semaglutide's profile ahead of its anticipated approval later this year as ...

Vivani Medical is developing GLP-1 subdermal implants that aim to provide a consistent therapeutic dose for six months, and ...

GLP-1 medications belong to a class of drugs that include semaglutide, liraglutide, dulaglutide, and several others. Semaglutide is the active ingredient in Wegovy and Ozempic, two popular GLP-1 ...

and dulaglutide (Trulicity). Semaglutide (Ozempic) and tirzepatide (Zepbound) were not included in the study. Obesity is associated with 13 cancers, and losing weight can slash that risk.

It may not be the mythical fountain of youth, but the strength of the body's immune system, or immune resilience, could hold the key to a healthy, long life, as it can help minimize inflammation.

The research will focus on the use of GLP-1 receptor agonist medications and their possible cognitive benefits in aging ...

Over two thirds of patients with hidradenitis suppurativa experience fewer flares, new lesions, and improved quality of life while using GLP-1 receptor agonists.

Novo Nordisk's early lead in weight-loss drugs fades as Eli Lilly surges ahead with more effective therapies and faster ...